Ample evidence from clinical and pre-clinical studies suggests mid-life hypercholesterolemia as a risk factor for developing Alzheimer’s disease (AD) at a later age. Hypercholesterolemia induced by dietary habits can lead to vascular perturbations that increase the risk of developing sporadic AD.
Objective:
To investigate the effects of a high fat/cholesterol diet (HFCD) as a risk factor for AD by using a rodent model of AD and its correspondent control (healthy animals).
Methods:
We compared the effect of a HFCD in normal mice (non-transgenic mice, NTg) and the triple transgenic mouse model of AD (3xTgAD). We evaluated cognitive performance in relation to changes in oxidative metabolism and neuron-derived nitric oxide (•NO) concentration dynamics in hippocampal slices as well as histochemical staining of markers of the neurovascular unit.
Results:
In NTg, the HFCD produced only moderate hypercholesterolemia but significant decline in spatial memory was observed. A tendency for decrease in •NO production was accompanied by compromised mitochondrial function with decrease in spare respiratory capacity. In 3xTgAD mice, a robust increase in plasma cholesterol levels with the HFCD did not worsen cognitive performance but did induce compromise of mitochondrial function and significantly decreased •NO production. We found increased staining of biomarkers for astrocyte endfeet and endothelial cells in 3xTgAD hippocampi, which was further increased by the HFCD.
Conclusion:
A short term (8 weeks) intervention with HFCD can produce an AD-like phenotype even in the absence of overt systemic hypercholesterolemia and highlights mitochondrial dysfunction as a link between hypercholesterolemia and sporadic AD.
ImtiazB, TolppanenA-M, KivipeltoM, SoininenH (2014) Future directions in Alzheimer’s disease from risk factors to prevention. Biochem Pharmacol88, 661–670.
2.
KivipeltoM, NganduT, FratiglioniL, ViitanenM, KareholtI, WinbladB, HelkalaEL, TuomilehtoJ, SoininenH, NissinenA (2005) Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol62, 1556–1560.
3.
SolomonA, KivipeltoM, WolozinB, ZhouJ, WhitmerRA (2009) Midlife serum cholesterol and increased risk of Alzheimer’s and vascular dementia three decades later. Dement Geriatr Cogn Disord28, 75–80.
4.
KivipeltoM, LaaksoMP, TuomilehtoJ, NissinenA, SoininenH (2002) Hypertension and hypercholesterolaemia as risk factors for Alzheimer’s disease: Potential for pharmacological intervention. CNS Drugs16, 435–444.
5.
CasserlyI, TopolE (2004) Convergence of atherosclerosis and Alzheimer’s disease: Inflammation, cholesterol, and misfolded proteins. Lancet363, 1139–1146.
6.
VagelatosNT, EslickGD (2013) Type 2 diabetes as a risk factor for Alzheimer’s disease: The confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev35, 152–160.
CorderE, SaundersA, StrittmatterW, SchmechelD, GaskellP, SmallG, RosesA, HainesJ, Pericak-VanceM (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science261, 921–923.
9.
BertramL, TanziRE (2008) Thirty years of Alzheimer’s disease genetics: The implications of systematic meta-analyses. Nat Rev Neurosci9, 768–778.
10.
GrammasP, MartinezJ, MillerB (2011) Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases. Expert Rev Mol Med13, e19.
11.
De la TorreJC, MussivandT (1993) Can disturbed brain microcirculation cause Alzheimer’s disease?Neurol Res15, 146–153.
12.
HumpelC (2011) Chronic mild cerebrovascular dysfunction as a cause for Alzheimer’s disease?Exp Gerontol46, 225–232.
13.
DiasC, LourençoCF, FerreiroE, BarbosaRM, LaranjinhaJ, LedoA (2016) Age-dependent changes in the glutamate-nitric oxide pathway in the hippocampus of the triple transgenic model of Alzheimer’s disease: Implications for neurometabolic regulation. Neurobiol Aging46, 84–95.
14.
YinF, SanchetiH, PatilI, CadenasE (2016) Energy metabolism and inflammation in brain aging and Alzheimer’s disease. Free Radic Biol Med100, 108–122.
KellerJN, SchmittF a, ScheffSW, DingQ, ChenQ, ButterfieldDA, MarkesberyWR (2005) Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology64, 1152–6.
17.
MiglioreL, FontanaI, TrippiF, ColognatoR, CoppedèF, TognoniG, NucciaroneB, SicilianoG (2005) Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging26, 567–573.
18.
MosconiL (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease: FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging32, 486–510.
19.
MosconiL, PupiA, De LeonMJ (2008) Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer’s disease. Ann N Y Acad Sci1147, 180–195.
20.
MosconiL, MisturR, SwitalskiR, TsuiWH, GlodzikL, LiY, PirragliaE, De SantiS, ReisbergB, WisniewskiT, De LeonMJ (2009) FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease. Eur J Nucl Med Mol Imaging36, 811–822.
21.
AsiimweN, YeoSG, KimM-S, JungJ, JeongNY (2016) Nitric oxide: Exploring the contextual link with Alzheimer’s disease. Oxid Med Cell Longev2016, 7205747.
LedoA, BarbosaRM, GerhardtGA, CadenasE, LaranjinhaJ (2005) Concentration dynamics of nitric oxide in rat hippocampal subregions evoked by stimulation of the NMDA glutamate receptor. Proc Natl Acad Sci U S A102, 17483–17488.
24.
PrastH, PhilippuA (2001) Nitric oxide as modulator of neuronal function. Prog Neurobiol64, 51–68.
25.
EdwardsTM, RickardNS (2007) New perspectives on the mechanisms through which nitric oxide may affect learning and memory processes. Neurosci Biobehav Rev31, 413–425.
26.
LedoA, LourençoCF, CadenasE, BarbosaRM, LaranjinhaJ (2021) The bioactivity of neuronal-derived nitric oxide in aging and neurodegeneration: Switching signaling to degeneration. Free Radic Biol Med162, 500–513.
27.
LourençoCF, LedoA, BarbosaRM, LaranjinhaJ (2017) Neurovascular-neuroenergetic coupling axis in the brain: Master regulation by nitric oxide and consequences in aging and neurodegeneration. Free Radic Biol Med108, 668–682.
28.
MoodleyKK, ChanD (2014) The hippocampus in neurodegenerative disease. Front Neurol Neurosci34, 95–108.
29.
OddoS, CaccamoA, ShepherdJD, MurphyMP, GoldeTE, KayedR, MetherateR, MattsonMP, AkbariY, LaFerlaFM (2003) Triple-transgenic model of Alzheimer’s disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron39, 409–421.
30.
LegerM, QuiedevilleA, BouetV, HaelewynB, BoulouardM, Schumann-BardP, FreretT (2013) Object recognition test in mice. Nat Protoc8, 2531–2537.
31.
SoaresE, PredigerRD, NunesS, CastroAA, VianaSD, LemosC, De SouzaCM, AgostinhoP, CunhaRA, CarvalhoE, Fontes RibeiroCA, ReisF, PereiraFC (2013) Spatial memory impairments in a prediabetic rat model. Neuroscience250, 565–577.
32.
FerreiraNR, LedoA, FradeJG, GerhardtGA, LaranjinhaJ, BarbosaRM (2005) Electrochemical measurement of endogenously produced nitric oxide in brain slices using Nafion/o-phenylenediamine modified carbon fiber microelectrodes. Anal Chim Acta535, 1–7.
33.
LedoA, BarbosaRM, LaranjinhaJ (2012) Modulation of cellular respiration by endogenously produced nitric oxide in rat hippocampal slices. Methods Mol Biol810, 73–88.
34.
DiasC, LourençoCF, BarbosaRM, LaranjinhaJ, LedoA (2018) Analysis of respiratory capacity in brain tissue preparations: High-resolution respirometry for intact hippocampal slices. Anal Biochem551, 43–50.
35.
PestaD, GnaigerE (2012) High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Methods Mol Biol810, 25–58.
36.
ClarkJK, FurgersonM, CrystalJD, FechheimerM, FurukawaR, WagnerJJ (2015) Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice. Neurobiol Learn Mem125, 152–162.
37.
KnightEM, MartinsIVA, GümüsgözS, AllanSM, LawrenceCB (2014) High-fat diet-induced memory impairment in triple-transgenic Alzheimer’s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology. Neurobiol Aging35, 1821–1832.
38.
AnsteyKJ, Ashby-MitchellK, PetersR (2017) Updating the evidence on the association between serum cholesterol and risk of late-life dementia: Review and meta-analysis. J Alzheimers Dis56, 215–228.
39.
DavidsonTL, HargraveSL, SwithersSE, SampleCH, FuX, KinzigKP, ZhengW (2013) Inter-relationships among diet, obesity and hippocampal-dependent cognitive function. Neuroscience253, 110–122.
40.
MoreiraELG, de OliveiraJ, EngelDFFF, WalzR, De BemAF, FarinaM, PredigerRDS (2014) Hypercholesterolemia induces short-term spatial memory impairments in mice: Up-regulation of acetylcholinesterase activity as an early and causal event?J Neural Transm121, 415–426.
SandersonDJ, BannermanDM (2012) The role of habituation in hippocampus-dependent spatial working memory tasks: Evidence from GluA1 AMPA receptor subunit knockout mice. Hippocampus22, 981–994.
43.
de OliveiraJ, HortMA, MoreiraELG, GlaserV, Ribeiro-do-ValleRM, PredigerRD, FarinaM, LatiniA, de BemAF (2011) Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: Relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress. Neuroscience197, 99–106.
44.
UllrichC, PirchlM, HumpelC (2010) Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits. Mol Cell Neurosci45, 408–417.
45.
HohsfieldLA, DaschilN, OräddG, StrömbergI, HumpelC (2014) Vascular pathology of 20-month-old hypercholesterolemia mice in comparison to triple-transgenic and APPSwDI Alzheimer’s disease mouse models. Mol Cell Neurosci63, 83–95.
46.
LöfflerT, SchweinzerC, FlunkertS, SánthaM, WindischM, SteyrerE, Hutter-PaierB (2016) Brain cortical cholesterol metabolism is highly affected by human APP overexpression in mice. Mol Cell Neurosci74, 34–41.
47.
LinB, HasegawaY, TakaneK, KoibuchiN, CaoC, Kim-MitsuyamaS (2016) High-fat-diet intake enhances cerebral amyloid angiopathy and cognitive impairment in a mouse model of Alzheimer’s disease, independently of metabolic disorders. J Am Heart Assoc5, e003154.
48.
De OliveiraJ, EngelDF, De PaulaGC, MeloHM, LopesSC, RibeiroCT, DelanogareE, MoreiraJCF, GelainDP, PredigerRD, GabilanNH, MoreiraELG, FerreiraST, De BemAF (2020) LDL receptor deficiency does not alter brain amyloid-β levels but causes an exacerbation of apoptosis. J Alzheimers Dis73, 585–596.
49.
BillingsLM, OddoS, GreenKN, McGaughJL, LaFerlaFM (2005) Intraneuronal Abeta causes the onset of early Alzheimer’s disease-related cognitive deficits in transgenic mice. Neuron45, 675–88.
50.
De OliveiraJ, EngelDF, De PaulaGC, Dos SantosDB, LopesJB, FarinaM, MoreiraELG, De BemAF (2020) High cholesterol diet exacerbates blood-brain barrier disruption in LDLr-/- mice: Impact on cognitive function. J Alzheimers Dis78, 97–115.
51.
SterniczukR, AntleMC, LaferlaFM, DyckRH (2010) Characterization of the 3xTg-AD mouse model of Alzheimer’s disease: Part 2. Behavioral and cognitive changes. Brain Res1348, 149–55.
52.
SahSK, LeeC, JangJ-H, ParkGH (2017) Effect of high-fat diet on cognitive impairment in triple-transgenic mice model of Alzheimer’s disease. Biochem Biophys Res Commun493, 731–736.
53.
EttchetoM, PetrovD, PedrósI, AlvaN, CarbonellT, Beas-ZarateC, PallasM, AuladellC, FolchJ, CaminsA (2016) Evaluation of neuropathological effects of a high-fat diet in a presymptomatic Alzheimer’s disease stage in APP/PS1 mice. J Alzheimers Dis54, 233–251.
54.
KnightEM, VerkhratskyA, LuckmanSM, AllanSM, LawrenceCB (2012) Hypermetabolism in a triple-transgenic mouse model of Alzheimer’s disease. Neurobiol Aging33, 187–193.
55.
RefoloLM, PappollaM a, MalesterB, LaFrancoisJ, Bryant-ThomasT, WangR, TintGS, SambamurtiK, DuffK (2000) Hypercholesterolemia accelerates the Alzheimer’s amyloid pathology in a transgenic mouse model. Neurobiol Dis7, 321–331.
56.
ChakrobortyS, KimJ, SchneiderC, WestAR, StutzmannGE (2015) Nitric oxide signaling is recruited as a compensatory mechanism for sustaining synaptic plasticity in Alzheimer’s disease mice. J Neurosci35, 6893–902.
57.
DrankaBP, HillBG, Darley-UsmarVM (2010) Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen species. Free Radic Biol Med48, 905–914.
JekabsonsMB, NichollsDG (2004) respiration and bioenergetic status of mitochondria in primary cerebellar granule neuronal cultures exposed continuously to glutamate. J Biol Chem279, 32989–33000.
65.
ButterfieldDA, PocernichCB (2003) The glutamatergic system and Alzheimer’s disease: Therapeutic implications. CNS Drugs17, 641–652.
YadavaN, NichollsDG (2007) Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone. J Neurosci27, 7310–7317.
68.
NichollsDG (2008) Oxidative stress and energy crises in neuronal dysfunction. Ann N Y Acad Sci1147, 53–60.
69.
DeslerC, HansenTL, FrederiksenJB, MarckerML, SinghKK, Juel RasmussenL (2012) Is there a link between mitochondrial reserve respiratory capacity and aging?J Aging Res2012, 192503.
70.
NamKN, MounierA, WolfeCM, FitzNF, CarterAY, CastranioEL, KambohHI, ReevesVL, WangJ, HanX, SchugJ, LefterovI, KoldamovaR (2017) Effect of high fat diet on phenotype, brain transcriptome and lipidome in Alzheimer’s model mice. Sci Rep7, 4307.
71.
Monteiro-CardosoVF, OliveiraMM, MeloT, DominguesMRM, MoreiraPI, FerreiroE, PeixotoF, VideiraRA (2014) Cardiolipin profile changes are associated to the early synaptic mitochondrial dysfunction in Alzheimer’s disease. J Alzheimers Dis43, 1375–1392.
72.
DietschyJM, TurleySD (2001) Cholesterol metabolism in the brain. Curr Opin Lipidol12, 105–112.
73.
IsasiE, BarbeitoL, Olivera-BravoS (2014) Increased blood-brain barrier permeability and alterations in perivascular astrocytes and pericytes induced by intracisternal glutaric acid. Fluids Barriers CNS11, 15.
74.
AcarinL, VelaJM, GonzálezB, CastellanoB (1994) Demonstration of poly-N-acetyl lactosamine residues in ameboid and ramified microglial cells in rat brain by tomato lectin binding. J Histochem Cytochem42, 1033–1041.
75.
SparksDL (2008) The early and ongoing experience with the cholesterol-fed rabbit as a model of Alzheimer’s disease: The old, the new and the pilot. J Alzheimers Dis15, 641–656.
76.
ChenX, GhribiO, GeigerJD (2008) Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis. Am J Physiol Regul Integr Comp Physiol294, R829–R835.
77.
KanoskiSE, ZhangY, ZhengW, DavidsonTL (2010) The effects of a high-energy diet on hippocampal function and blood-brain barrier integrity in the rat. J Alzheimers Dis21, 207–219.
